ScripsAmerica Stock

ScripsAmerica EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ScripsAmerica (SCRCQ) as of Aug 19, 2026 is -3.81 M USD.

EBITDA

-3.81 MUSD

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ScripsAmerica is 2026 -3.81 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ScripsAmerica was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

ScripsAmerica Stock analysis

What does ScripsAmerica do? ScripsAmerica Inc. is a US pharmaceutical company that specializes in the healthcare sector. The company offers a wide range of products and services primarily used in the healthcare industry. ScripsAmerica is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ScripsAmerica stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ScripsAmerica is -3.81 M USD in 2026.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) ScripsAmerica since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ScripsAmerica historically and in real time.

Access this data via the Eulerpool API

Income Statement — ScripsAmerica

All Key Metrics — ScripsAmerica